InsidersTradesSigma
Hamlet BioPharma AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Hamlet BioPharma AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Hamlet BioPharma AB has logged 8 reports. Market capitalisation: €1.3bn. The latest transaction was disclosed on 25 May 2026 (Sale). Among the most active insiders: Henrik Sundin. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€76,774
8 ops.
Sell Volume
14Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 May 2026
Declarations8 total
10,000 shares@ SEK 7.490.0005% mcap9.0% of flowAktieFI:csv-5b71b289a4ac40e47ab5
20,000 shares@ SEK 7.650.0011% mcap18.2% of flowAktieFI:csv-69bdd949cde8b5d12cf1
10,000 shares@ SEK 7.610.0005% mcap9.1% of flowAktieFI:csv-74c6872ba2c9fa3745f0
20,000 shares@ SEK 7.700.0011% mcap18.3% of flowAktieFI:csv-17884beb14cceb2d6251
10,000 shares@ SEK 7.580.0005% mcap9.0% of flowAktieFI:csv-8b1223654d29b5466fcb
10,000 shares@ SEK 7.630.0005% mcap9.1% of flowAktieFI:csv-628a2bf8649801cf1f97
10,000 shares@ €0.689432.9% of flowAktieFI:A003Z114-1
20,000 shares@ €0.703767.1% of flowAktieFI:A003Z083-1
8 of 8 declarations